🔥🐔 BizChicken 🐔🔥

Companies Similar to Daré Bioscience, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

BioAtla, Inc.

BioAtla, Inc. logo
Market Cap: Low
Employees: Low

BA3011

Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.

Tags: antibody-based therapeutics, biopharmaceutical, cancer, clinical stage, solid tumor

Symbol: BCAB

Recent Price: $0.59

Industry: Biotechnology

CEO: Dr. Jay M. Short Ph.D.

Sector: Healthcare

Employees: 65

Address: 11085 Torreyana Road, San Diego, CA 92121

Phone: 858 558 0708

Last updated: 2024-12-31

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

CAP-1002

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company specializing in developing transformative cell and exosome-based therapeutics aimed at treating and preventing a range of diseases and disorders. Their lead candidate, CAP-1002, is designed for Duchenne muscular dystrophy and cytokine storm interventions.

Tags: COVID-19, Duchenne muscular dystrophy, biotechnology, cell therapy, therapeutics

Symbol: CAPR

Recent Price: $13.76

Industry: Biotechnology

CEO: Dr. Linda Marbán Ph.D.

Sector: Healthcare

Employees: 101

Address: 10865 Road to the Cure, San Diego, CA 92121

Phone: 310 358 3200

Leadership

  • Linda Marbán, Ph.D., Chief Executive Officer and Director
  • Kristi A. H. Elliott, Ph.D., Chief Science Officer
  • AJ Bergmann, M.B.A., Chief Financial Officer
  • Karen G. Krasney, J.D., Executive Vice President and General Counsel
  • Mark Awadalla, Vice President of Clinical Operations
  • Jonathan Tayco, Vice President of Program Management and Business Operations
  • Minghao Sun, Ph.D., Vice President of Research and Product Development
  • Yushi Feng, Ph.D., Vice President of Regulatory Affairs
  • Frank Litvack M.D., FACC, Executive Chairman
  • Paul G. Auwaerter, M.D., M.B.A., FIDSA, Director
  • Earl M. (Duke) Collier Jr., Director
  • George W. Dunbar, Jr., Director
  • Philip J. Gotwals, Ph.D., Director
  • Michael Kelliher, Director
  • David B. Musket, Director
  • Karimah Es Sabar, Director

Last updated: 2024-12-31

Daré Bioscience, Inc.

Daré Bioscience, Inc. logo
Market Cap: Lowest
Employees: Lowest

XACIATO

Daré Bioscience, Inc. is a clinical-stage biopharmaceutical company focused on developing and marketing products for women's health, including therapies for contraception, fertility, and sexual and vaginal health.

Tags: biopharmaceutical, contraception, fertility, vaginal health, women's health

Symbol: DARE

Recent Price: $3.23

Industry: Biotechnology

CEO: Ms. Sabrina Martucci Johnson

Sector: Healthcare

Employees: 23

Address: 3655 Nobel Drive, San Diego, CA 92122

Phone: 858 926 7655

Last updated: 2024-12-31

ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ORIC-533, ORIC-944, ORIC-114

ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.

Tags: ORIC-114, ORIC-533, ORIC-944, biopharmaceutical, cancer treatment, clinical-stage

Symbol: ORIC

Recent Price: $8.17

Industry: Biotechnology

CEO: Dr. Jacob M. Chacko M.B.A., M.D.

Sector: Healthcare

Employees: 107

Address: 240 East Grand Avenue, South San Francisco, CA 94080

Phone: 650 388 5600

Last updated: 2024-12-31

TherapeuticsMD, Inc.

TherapeuticsMD, Inc. logo
Market Cap: Lowest
Employees: Lowest

IMVEXXY, BIJUVA, ANNOVERA

Therapeutics MD, Inc. operates as a women's healthcare company in the United States, providing treatments for conditions like dyspareunia and vasomotor symptoms, and offering contraceptive solutions and prenatal vitamins.

Tags: Contraceptives, Dyspareunia Treatment, Prenatal Vitamins, Vasomotor Symptoms, Women's Healthcare

Symbol: TXMD

Recent Price: $1.03

Industry: Drug Manufacturers - Specialty & Generic

CEO: Mr. Marlan D. Walker J.D.

Sector: Healthcare

Employees: 1

Address: 951 Yamato Road, Boca Raton, FL 33431

Phone: 561 961 1900

Leadership

  • Marlan Walker, Chief Executive Officer
  • Joe Ziegler, Principle Financial Officer

Last updated: 2024-12-31

Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

Endoxifen

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for oncology and infectious diseases with key programs in breast cancer and COVID-19 treatment.

Tags: COVID-19, Endoxifen, biopharmaceutical, breast cancer, infectious diseases, oncology

Symbol: ATOS

Recent Price: $0.97

Industry: Biotechnology

CEO: Dr. Steven C. Quay FCAP, M.D., Ph.D.

Sector: Healthcare

Employees: 12

Address: 107 Spring Street, Seattle, WA 98104

Phone: 206 588 0256

Last updated: 2024-12-31

Biomerica, Inc.

Biomerica, Inc. logo
Market Cap: Lowest
Employees: Low

diagnostic and therapeutic products

Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.

Tags: biomedical, diabetes, diagnostic, food intolerances, gastrointestinal, therapeutic

Symbol: BMRA

Recent Price: $0.31

Industry: Medical - Devices

CEO: Mr. Zackary S. Irani

Sector: Healthcare

Employees: 64

Address: 17571 Von Karman Avenue, Irvine, CA 92614

Phone: 949 645 2111

Last updated: 2024-12-31

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

Fadraciclib, CYC140, Sapacitabine, Seliciclib

Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of medicines for treating cancer and other proliferative diseases. The company's key development programs include fadraciclib, CYC140, Sapacitabine, and seliciclib, targeting various forms of cancer and other conditions.

Tags: CDK inhibitors, biopharmaceutical, cancer treatment, clinical trials, proliferative diseases

Symbol: CYCC

Recent Price: $0.37

Industry: Biotechnology

CEO: Mr. Spiro George Rombotis

Sector: Healthcare

Employees: 12

Address: 200 Connell Drive, Berkeley Heights, NJ 07922

Phone: 908 517 7330

Last updated: 2024-12-31

DarioHealth Corp.

DarioHealth Corp. logo
Market Cap: Lowest
Employees: Low

Dario's metabolic solutions

Dario Health Corp. is a digital therapeutics company offering solutions for metabolic health, MSK conditions, behavioral health, and chronic condition management.

Tags: MSK conditions, behavioral health, diabetes, digital therapeutics, healthcare technology, hypertension, metabolic health, weight management

Symbol: DRIO

Recent Price: $0.79

Industry: Medical - Diagnostics & Research

CEO: Mr. Erez Raphael

Sector: Healthcare

Employees: 223

Address: 18 West 18th Street, New York, NY 10011

Phone: 833 914 3796

Last updated: 2024-12-31

Erasca, Inc.

Erasca, Inc. logo
Market Cap: Medium
Employees: Low

ERAS-007, ERAS-601, ERAS-801

Erasca, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.

Tags: ERAS-007, ERAS-601, ERAS-801, RAS/MAPK, biopharmaceutical, cancers

Symbol: ERAS

Recent Price: $2.55

Industry: Biotechnology

CEO: Dr. Jonathan E. Lim M.D.

Sector: Healthcare

Employees: 126

Address: 10835 Road to the Cure, San Diego, CA 92121

Phone: 858 465 6511

Last updated: 2024-12-31

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc. logo
Market Cap: High
Employees: Medium

Crysvita, Mepsevii, Dojolvi, Evkeeza, DTX401, DTX301

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on the development and commercialization of products for rare and ultra-rare genetic diseases worldwide.

Tags: Crysvita, Dojolvi, Evkeeza, Mepsevii, biopharmaceutical, gene therapy, genetic diseases, rare diseases

Symbol: RARE

Recent Price: $42.27

Industry: Biotechnology

CEO: Dr. Emil D. Kakkis M.D., Ph.D.

Sector: Healthcare

Employees: 1276

Address: 60 Leveroni Court, Novato, CA 94949

Phone: 415 483 8800

Last updated: 2024-12-31

Sana Biotechnology, Inc.

Sana Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

N/A

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.

Tags: biotechnology, cell engineering, genetic disorders, medicine, oncology

Symbol: SANA

Recent Price: $1.61

Industry: Biotechnology

CEO: Dr. Steven D. Harr M.D.

Sector: Healthcare

Employees: 328

Address: 188 East Blaine Street, Seattle, WA 98102

Phone: 206 701 7914

Last updated: 2024-12-31

Scopus BioPharma Inc.

Scopus BioPharma Inc. logo
Market Cap: Lowest
Employees: Lowest

Duet Platform

Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.

Tags: biopharmaceutical, cancer treatment, gene therapy, immuno-oncology, therapeutics

Symbol: SCPS

Recent Price: $0.00

Industry: Biotechnology

CEO: Dr. Alan D. Horsager Ph.D.

Sector: Healthcare

Employees: 13

Address: 420 Lexington Avenue, New York, NY 10170

Phone: 212 479 2513

Last updated: 2024-12-31

Sagimet Biosciences Inc.

Sagimet Biosciences Inc. logo
Market Cap: Low
Employees: Lowest

Denifanstat

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics called fatty acid synthase (FASN) inhibitors for diseases caused by dysfunctional lipid metabolism pathways. Its lead drug candidate, Denifanstat, targets nonalcoholic steatohepatitis and acne. The company is also working on FASN inhibitors for cancer treatment.

Tags: Denifanstat, FASN inhibitors, acne, biopharmaceutical, cancer, nonalcoholic steatohepatitis

Symbol: SGMT

Recent Price: $4.72

Industry: Biotechnology

CEO: Mr. David A. Happel

Sector: Healthcare

Employees: 8

Address: 155 Bovet Road, San Mateo, CA 94402

Phone: 650-561-8600

Leadership

  • George Kemble, PhD, Executive Chairman of the Board
  • David Happel, Chief Executive Officer
  • Anne Phillips, MD,
  • Beth Seidenberg, MD,
  • Elizabeth Grammer, Esq,
  • Jennifer Jarrett,
  • Merdad Parsey, MD, PhD,
  • Paul Hoelscher,
  • Tim Walbert,

Last updated: 2024-12-31

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Low

Tamibarotene

Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.

Tags: acute myeloid leukemia, biopharmaceutical, cancer treatment, gene control, myelodysplastic syndrome, pharmaceutical development

Symbol: SYRS

Recent Price: $0.25

Industry: Biotechnology

CEO: Mr. Conley Chee

Sector: Healthcare

Employees: 68

Address: 35 CambridgePark Drive, Cambridge, MA 02140

Phone: 617 744 1340

Leadership

  • Conley Chee, President and Chief Executive Officer
  • Jason Haas, Chief Financial Officer
  • Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
  • Lisa Roberts, VP Human Resources
  • David A. Roth, M.D., Chief Medical Officer
  • Kristin Stephens, Chief Development Officer

Last updated: 2024-12-31

Veracyte, Inc.

Veracyte, Inc. logo
Market Cap: High
Employees: Medium

Afirma Genomic Sequencing Classifier, Xpression Atlas, Decipher Prostate, Prosigna Breast Cancer Assay, Percepta Genomic Sequencing Classifier, Envisia Genomic Classifier, Immunoscore Colon Cancer test

Veracyte, Inc. operates as a diagnostics company worldwide, providing genomic testing solutions for various cancers and diseases, aiming to improve outcomes by avoiding unnecessary surgeries and enhancing treatment decisions.

Tags: Biotechnology, Cancer Diagnosis, Diagnostics, Genomic Testing, Healthcare, Medical Devices

Symbol: VCYT

Recent Price: $40.00

Industry: Biotechnology

CEO: Mr. Marc A. Stapley

Sector: Healthcare

Employees: 815

Address: 6000 Shoreline Court, South San Francisco, CA 94080

Phone: 650 243 6300

Last updated: 2024-12-31

Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc. logo
Market Cap: Lowest
Employees: Lowest

XCART

Xenetic Biosciences, Inc. is a biopharmaceutical company that focuses on advancing XCART, a personalized CAR T platform technology for oncology therapeutics and biologic drug development.

Tags: CAR T, biopharmaceutical, biotechnology, drug delivery, oncology, therapeutics

Symbol: XBIO

Recent Price: $4.05

Industry: Biotechnology

CEO: Mr. James F. Parslow

Sector: Healthcare

Employees: 4

Address: 40 Speen Street, Framingham, MA 01701

Phone: 781 778 7720

Leadership

  • James F. Parslow, Interim Chief Executive Officer and Chief Financial Officer
  • Scott N. Cullison, Business Development
  • Reid P. Bissonnette, Ph.D., Translational Research and Development
  • Cory C. Kauffman, Ph.D., Chief Technology Officer
  • Adam Logal, Chairman
  • Grigory G. Borisenko, Ph.D., Non-Executive Director
  • James Eric Callaway, Ph.D., Non-Executive Director
  • Firdaus Jal Dastoor, FCS, Non-Executive Director
  • Dmitry Genkin, MD, Non-Executive Director
  • Roger Kornberg, Ph.D., Non-Executive Director
  • Moshe Mizrahy, Non-Executive Director
  • Dr. Alexey Vinogradov, Non-Executive Director

Last updated: 2024-12-31

XBiotech Inc.

XBiotech Inc. logo
Market Cap: Low
Employees: Low

True Human monoclonal antibodies

XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies targeting inflammatory and infectious diseases, with additional development in interleukin-1 alpha therapies for various medical conditions and COVID-19 therapy.

Tags: COVID-19, antibodies, biopharmaceutical, cancer, diseases, inflammation, therapies

Symbol: XBIT

Recent Price: $4.09

Industry: Biotechnology

CEO: Mr. John Simard

Sector: Healthcare

Employees: 94

Address: 5217 Winnebago Lane, Austin, TX 78744

Phone: 512 386 2900

Last updated: 2024-12-31

X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc. logo
Market Cap: Low
Employees: Low

mavorixafor

X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.

Tags: CXCR4, biopharmaceutical, clinical trials, mavorixafor, rare diseases, therapeutics

Symbol: XFOR

Recent Price: $0.81

Industry: Biotechnology

CEO: Dr. Paula Ragan Ph.D.

Sector: Healthcare

Employees: 127

Address: 61 North Beacon Street, Boston, MA 02134

Phone: 857 529 8300

Last updated: 2024-12-31

Xencor, Inc.

Xencor, Inc. logo
Market Cap: High
Employees: Low

Monoclonal Antibody and Cytokine Therapeutics

Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.

Tags: autoimmune diseases, biopharmaceutical, cancer treatment, cytokines, monoclonal antibodies

Symbol: XNCR

Recent Price: $23.71

Industry: Biotechnology

CEO: Dr. Bassil I. Dahiyat Ph.D.

Sector: Healthcare

Employees: 280

Address: 111 West Lemon Avenue, Monrovia, CA 91016

Phone: 626 305 5900

Last updated: 2024-12-31